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This monograph forms part of a series of disease monographs commissioned by the 
International Development Research Centre over the period Nov 2015 to April 2016 to 
inform funding priorities for the Livestock Vaccine Innovation Fund (LVIF). The LVIF is a 
seven-and-a-half year, CA$57 million partnership between the Bill & Melinda Gates 
Foundation, Global Affairs Canada and Canada’s International Development Research 
Centre. It focuses on those animal diseases posing the greatest risk to poor livestock 
keepers in Sub-Saharan Africa, South and Southeast Asia, targeting transboundary 
diseases to achieve lasting regional impact. 
 
The content presented here is as submitted by the consultant(s) involved and has been 
edited for appearance only. The views, information, or opinions expressed in this 
monograph are solely those of the individual consultant(s) involved and do not 
necessarily represent those of the Bill & Melinda Gates Foundation, Global Affairs Canada 
and International Development Research Centre, or any of their employees. Sections of 
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Etiology and relevance 
Theileriosis results from infection with protozoa in the genus Theileria of the suborder Piroplasmorina. Theileria 
spp. are obligate intracellular parasites.  The two most important species in cattle and water buffalo are T. 
parva, which causes East Coast fever (ECF), and T. annulata, which causes tropical theileriosis. The present 
monograph focuses on T. parva and ECF. ECF is considered to be the most economically devastating tick-borne 
disease of cattle in Africa.   
 
Epidemiology and transmission 
While T. parva occurs in 13 Eastern and Southern African countries, only 11 of them have ECF, South Africa and 
Swaziland having exclusively Corridor disease.  
T. parva is transmitted transstadially by the three-host ticks, Rhipicephalus appendiculatus, Rhipicephalus 
zambeziensis and Rhipicephalus duttoni. R. appendiculatus is the most important vector. The African buffalo 
(Syncerus caffer) is the natural reservoir host of T. parva and infections in buffalo are usually asymptomatic, but 
are acute and usually fatal in cattle. The African buffalo is an indigenous bovine of sub-Saharan Africa and has 
lived in harmony with T. parva and its vector R. appendiculatus long before cattle were introduced into the 
region. Other reservoir hosts of T. parva are water buffalo (Bubalus bubalis) and waterbuck (Kobus defassa).  
 
Clinical signs 
The clinical signs of ECF include generalized lymphadenopathy, fever, anorexia and loss of condition with 
decreased milk yield. Petechia and ecchymosis may be found on the conjunctiva and oral mucous membranes. 
Terminally ill animals often develop pulmonary oedema, severe dyspnoea and a frothy nasal discharge. Some 
cattle have a fatal condition called “turning sickness.” In this form of the disease, infected cells block capillaries 
in the central nervous system and cause neurological signs. Animals that recover from ECF often become 
asymptomatic carriers, but some animals have poor productivity and their growth is stunted.  
 
Diagnosis 
Diagnosis of ECF is principally based on clinical signs, knowledge of disease and vector distribution, and 
identification of parasites in Giemsa-stained blood and lymph node smears.   
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Clinically ECF should be suspected in tick–infested animals with a fever and enlarged lymph nodes. Terminal 
pulmonary edema and a high mortality rate in introduced breeds are also suggestive. Indigenous animals with 
tropical theileriosis may be in poor condition, with wasting and signs of anemia.  
For laboratory diagnosis in live animals, ECF can be diagnosed by finding schizonts in Giemsa-stained thin smears 
from blood or lymph node biopsies. At necropsy, schizonts may be found in impression smears from many 
internal organs. Piroplasms occasionally occur in the blood of carrier animals, but in many cases, they cannot be 
detected by direct examination. The diagnosis must be confirmed by detecting schizonts.  
 The most widely used diagnostic test for T. parva has been the indirect fluorescent antibody (IFA) test. 
However, because of the problems of cross-reactivity among some Theileria species, the test has limitations for 
large-scale surveys in areas where species distribution overlaps. The IFA test for T. parva does not distinguish 
among the different immunogenic stocks. ELISA tests based on both crude and specific antigens have been 
developed and can detect antibodies to Theileria antigens approximately 20 days after infection. Molecular 
tests, especially PCR assays and sequencing also have been developed and are often used for characterising 
species and parasite polymorphisms, defining population genetics and generating epidemiological data.    
 ECF is the most economically important tick-borne disease in Africa due to the mortality, morbidity and 
production losses it causes. Indirectly it also impacts on other economic aspects, affecting agriculture, mining 
and commerce, all of which still used ox-drawn transport.  
With more than 38% of the African total bovine population affected and an estimated mortality of 1.1 million 
cattle per year, ECF remains probably the most important cattle disease in terms of economic losses and 
restriction of livestock development in affected countries of eastern, central and parts of southern Africa.  
 
Control 
In endemic regions, the main methods in the control of ECF include tick control, host immunization, 
chemotherapy and integrated control that combines any of the methods. Chemical control of ticks with 
acaricides is still the most practical and widely used method for the control of ECF. However, tick control 
practices are not always fully effective for a number of reasons, including development of acaricide resistance, 
the high cost of acaricides, poor management of tick control, and illegal cattle movement in many countries.  
Several drugs, legal and substandard, are widely used in the treatment of clinical disease, sometimes to good 
effect, but they have not proved to be completely reliable therapeutic agents.   
  
The only immunisation method that has been possible to use to date is the infection and treatment Method 
(ITM) in which cattle are given a subcutaneous dose of tick-derived sporozoites and a simultaneous treatment 
with a long-acting tetracycline formulation. This treatment results in a mild or inapparent ECF reaction followed 
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by recovery. Recovered animals demonstrate a robust immunity to homologous challenge, which usually lasts 
for the lifetime of an animal. The most widely used and studied ITM is the Muguga cocktail, developed in Kenya 
and comprising 3 stocks (T. parva Muguga and T. parva Kiambu 5 and buffalo-derived T. parva Serengeti 
transformed) in order to provide broader immunity to different isolates.    
  
Through extensive efforts of several organisations and program few batches of the ECF ITM Muguga cocktail 
were produced at ILRI and made available to livestock keepers in East African countries the most affected by the 
disease. Although produced at an approximate cost of $USD2, the cost to the farmer has been around $USD10 – 
$USD15 per animal.  The high cost is associated with storage requirements of stabilate for transport (liquid 
nitrogen), oxytetracycline for the treatment (from $USD2-8) and veterinary professional care required for the 
ITM process.  Despite the cost, the farmers recognize the benefit of protecting their herds and pay for treatment 
by selling a few of their animals. The major disincentive for use of ITM by the farmers has been the unreliable 
and inconsistent supply. Through a GALVmed funded program, the CTTBD in Malawi was supported to produce 
more batches of the vaccine, and is still being supported for the process and product improvement.  
  
Although the ITM vaccine is credited with saving 620,000 cows since its use in the most affected countries, the 
need for more immunisation is still not being met, and the vaccine has several shortcomings. One of the major 
problem associated with the ITM is the inoculation of live parasites, which makes it difficult to provide a product 
that is safe and which can be easily delivered to farmers. In addition, cross-immunity studies and field challenge 
of animals immunised by this method have shown that different immunological types of the parasite exist, and 
that the immunity is strain- or stock-specific. Furthermore, the ITM Muguga cocktail has been shown not to be 
protective on buffalo-derived T. parva.   
  
The presence of sporozoite neutralizing antibodies in cattle repeatedly exposed to field infection, or to 
sporozoites by stabilate inoculation, provided the rationale for the development of a potential vaccine based on 
a recombinant sporozoite surface antigen of T. parva, known as recombinant p67. The cloned gene encoding 
p67, and expressed bacterially or insect cells induced protection in cattle against experimental needle challenge 
with a lethal dose of sporozoites. However, the results showed consistently approximately 70% protection 
against lethal needle challenge with sporozoite stabilates in susceptible taurine cattle in the laboratory. In 
subsequent field trials conducted in Kenya, with different p67 vaccines in order to determine protective efficacy 
against tick challenge, within different production systems and epidemiological situations, could demonstrate 
reduction in severe disease of only 47–50% relative to un-immunized cattle. More peptides had been identified 
and characterized which are believed to enhance the protection level afforded by p67, when administered as a 
cocktail.  
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Based on these initial results, a new initiative has been funded by the BMGF for the establishment of an ILRI-led 
ECF consortium made of all global institutions involved in a way or another in ECF vaccine research. This 
consortium, funded for 4 years to the tune of USD11million, will look into improvement of the ITM Muguga 
cocktail and also new generation vaccines, building on work conducted to date.   
  
To date there are two programs looking into ECF vaccine: the work through the ILRI-led ECF consortium and the 
ITM production process improvement work at CTTBD.   
The future of ECF vaccines and vaccination   
 
The funding of ECF vaccine research through the ECF consortium gives hope for a possible better vaccine against 
this devastating disease. There is a need meanwhile to improve availability and access in the field of the current 
ECF ITM to as many affected livestock keepers as possible. It would also be important to intensify the vaccine 
matching effort of different isolates from different part of affected regions.     
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There are a number of species of Theileria spp. that infect cattle; the two most pathogenic and economically 
important are T. parva and T. annulata. Theileria parva occurs in 13 countries in sub-Saharan Africa causing East 
Coast fever (ECF), whilst T. annulata (Tropical/Mediterranean theileriosis) occurs in southern Europe as well as 
North Africa and Asia [21]. The present monograph will focus on T. parva and East Coast Fever (ECF).  
ECF, also referred to as Theileriosis, in its classical form is a usually fatal disease of cattle caused by Theileria 
parva. It is transmitted principally by the brown ear tick Rhipicephalus appendiculatus and is characterized by 
the proliferation of lymphoblasts infected with theilerial schizonts throughout the body, particularly in the 
lymph nodes, lymphoid aggregates, spleen, kidneys, liver and lungs. The disease occurs widely through the range 




Theileria is a genus comprising tick-transmitted parasitic protozoa in the family Theileriidae, order Piroplasmida, 
subclass Piroplasmia, phylum Apicomplexa.  Theileriae are obligate intracellular protozoan parasites that infect 
both wild and domestic Bovidae throughout much of the world (some species also infect small ruminants). They 
are transmitted by ixodid ticks, and have complex life cycles in both vertebrate and invertebrate hosts.   
Besides the already mentioned T. parva and T. annulata, there are some mildly pathogenic and benign species 
of Theileria that infect cattle and buffalo in Africa such as T. mutans, a species which is usually non-pathogenic, 
although it may cause severe or fatal disease in East Africa, T. buffeli, which was originally identified in Asiatic 
buffalo and also is found in African buffaloes [9], T. velifera, T. bujJeli, Theileria taurotragi and Theileria sp. 
(buffalo) [1][4]. See Table 1 for the parasites, vectors and diseases.   
Originally described as a single species, it was for a period divided into three subspecies: T. parva parva (the 
cause of classical East Coast fever); T. parva lawrencei (the cause of Corridor disease); and T. parva bovis (the 
cause of Zimbabwe theileriosis). This subdivision has now been abandoned [18][21].  
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Another important point worth noting is the fact that isolates and vaccine strains are generally named or 
referred to based on the geographic area where they were isolated. It has been suggested by several experts 
that a genotypic-based nomenclature would be preferable, as it will also dissipate some of the current conflicts 
and perceived fears of introducing foreign isolates in some regions believed to have different isolates (personal 
communication with T. Musoke, F. Musisi and S. Morzaria).   
To date the most studied isolates are those included in the Muguga cocktail, which includes the cattle-derived T. 
parva Muguga and T. parva Kiambu 5 and buffalo-derived T. parva Serengeti transformed.  
More recent sequencing work by Norling et al [15] has demonstrated points often noted that, the 
Serengetitransformed stock is very similar genetically to the Muguga stock.    
From studies of the Muguga isolate, immunodominant antigens of the parasite have been identified as falling 
into the two categories of potential candidate vaccine antigens: p67 and PIM as sporozoite antigens [14] and Tp1, 




Susceptible animal species   
T. parva can infect cattle, African buffalo (Syncerus caffer), water buffalo (Bubalus bubalis), and waterbucks 
(Kobus spp.). Symptomatic infections are common only in cattle and water buffalo.  
T. parva is probably originally a parasite of African buffalo which has become adapted to cattle. It has been 
found to infect waterbuck (Kobus defassa) under natural conditions, and the Asiatic buffalo (Bubalus bubalis) 
under experimental conditions [9]. It is not infective to other ungulates, nor to any species of laboratory animal. 
There is no evidence that wildlife plays any role in the epidemiology of the disease.  
There is a marked variation in the susceptibility of cattle to infection. Taurine breeds are generally more 
susceptible than Zebu and Sanga breeds. In addition, there are variations within breeds depending on the 
epidemiological state of East Coast fever.  
 Vector of ECF  
The occurrence of ECF closely follows the geographic distribution of the main vector Rhipicephalus 
appendiculatus, a three host ixodid tick (Figures 1 & 2). R. appendiculatus is widely distributed throughout the 
warmer, more humid areas of eastern, central and southern Africa. Within its range its abundance varies 
considerably, being governed by soil moisture and temperature, presence of suitable habitat and availability of 
hosts. The distribution of climatic suitability has been plotted on the basis of ecoclimatic indices.[9] Interestingly, 
areas of ecoclimatic suitability exist where the presence of the tick has yet to be recorded [16] illustrating that 
other factors also play a role in determining distribution. Among these is vegetation cover, which influences the 
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microclimate of the habitat of the tick; overgrazing has a marked adverse effect on the tick population [12][9]. Also 
important is the livestock production system employed, particularly with respect to how management affects 
exposure to ticks. Thus in Kenya there is a considerable difference in tick infestation levels and corresponding 
infection prevalence between open grazing and stall-feeding (zero grazing) management systems [5].  








Figure 1: Rhipicephalus appendiculatus - Brown ear tick 
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Figure 2: Life cycle of Rhipicephalus appendiculatus hard tick. Eggs at far left, then unfed and engorged 
larvae, unfed and engorged nymphs, unfed female and male top right, fully engorged female bottom right; 




Life cycle of Theileiria parva  
T. parva has a typical apicomplexan life cycle (Figure 3) with an alternation of sexual and asexual stages that are 
found in the mammalian and tick host. T. parva alternates between cattle and ticks and its life cycle involves the 
sequential invasion of two different cell types in the cattle host, and a sexual cycle in the vector. Ticks become 
infected with T. parva when they feed on cattle or buffalo carrying in their erythrocytes the piroplasm stage of 
the parasite. Piroplasme are released within the tick gut and differentiate into male and females gametes. Pairs 
of gametes fuse to produce diploid zygotes. These will invade cells in the gut wall and undergo a two-step 
meiotic division, resulting in large number of developmental stages which develop into motile kinetes and 
migrate to the salivary glands through the heamolymph. The kinete is now called a sporont. During tick feeding, 
sporoblasts are produced in a sporogony process of nuclear mitotic division. Maturation is then stimulated and 
haploid sporozoites are produced after three to four days feeding. These infective sporozoites are subsequently 
released into the saliva and injected into the mammalian host when ticks are taking their blood meal. Inoculated 
sporozoites invade bovine T and B lymphocytes by a complex receptor-mediated process and begin to develop. 
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The parasite completes the first stage of its lifecycle in lymphocytes which consists in a logarithmic 
multiplication phase (schizogony) and the formation of the invasive forms (merogony) for the next stage. [1]  
Resulting merozoites are liberated from the lymphocytes and invade the erythrocytes in which they are referred 
to as piroplasms. The erythrocytic stages are infective to ticks and are characterised by limited proliferation. This 
is in marked contrast to most of the other members of the Piroplasmia in which the main multiplication phase 




Figure 3: Lifecycle of Theileria parva 
 
Distribution  
T. parva are found only in Africa, in 13 Eastern, Central and Southern African countries: Burundi, Democratic 
Republic of Congo, Kenya, Malawi, Mozambique, Rwanda, South Sudan, South Africa, Swaziland, Tanzania, 
Uganda, Zambia and Zimbabwe [24], as shown in Figure 4 below. ECF on the other hand is considered to occur in 
11 countries, since South Africa and Swaziland have rather Corridor disease.   
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Figure 4: Distribution range of T. parva and distribution of R. appendiculatus [11]  
 
Endemic stability and instability  
Three major epidemiological forms or states of East Coast fever are recognized: endemic stability, endemic 
instability and epidemic.  Under certain specific circumstances, ECF can exist in an endemic form in which it has 
little or no influence on morbidity and mortality in the herd. According to Lawrence et al. [9] this situation, which 
was first recognized in Uganda, is now commonly referred to as endemic stability. However, endemic stability to 
T. parva infection appears to be relatively limited in its distribution and may not be achieved easily. The more 
common situation seen in the region is that of endemic instability, in which varying degrees of clinical disease 
are experienced.  
Endemic stability: implies an ecological balance between cattle, tick and parasite in which regular transmission 
of T. parva occurs in all age groups of the cattle population and high levels of population immunity are achieved, 
with minimal effects in terms of morbidity and mortality. This is most commonly achieved in areas where 
indigenous Zebu cattle are kept on pasture in areas highly suitable for the vector, and where major seasonal 
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fluctuations in vector abundance do not occur. Infection prevalence in ticks may be in the region of 1 or 2 per 
cent, infection intensity in infected ticks is low, infection of calves takes place early in life, and reinfection 
throughout life is common.   
Endemic stability is characterised by a high (70%) seroprevalence but low incidence of theileriosis, and low 
theileriosis fatality rates.   
It is most common in the smallholder systems prevalent in the humid areas surrounding the Lake Victoria basin, 
where the presence of endemic T. parva infection in cattle prohibits or severely limits the keeping of more 
productive taurine breeds of cattle.  
Endemic instability: Endemic instability is found in two forms, low incidence and high incidence. Low incidence 
instability is found in areas of very low infection challenge, either in areas marginally suitable for the vector or 
on properties where acaricides are applied intensively. High incidence instability is characterized by an infection 
challenge that is insufficient to induce population immunity. This can be as a result of ineffective tick control, or 
intermediate levels of infection challenge.  
Low incidence endemic instability is found on the large-scale commercial beef ranches of the entire region, and 
in the small-scale dairy systems of Kenya [5].  
High incidence instability is characteristic of newer commercial ventures, in which an upgrading of indigenous 
cattle is undertaken through crossbreeding, and tick control is ineffective. Under such circumstances, and in 
epidemic ECF, the case fatality may be extremely high [5].  
Epidemic ECF occurs when the disease is introduced to areas previously free of the disease, and often occurs on 




East Coast fever in the classical form is characterized by pyrexia, enlargement of the superficial lymph nodes, 
severe pulmonary oedema and wasting. It usually terminates in death.  The period and the course of the disease 
become shorter as the challenge is increased. The first clinical signs are fever and increases in pulse and 
respiration rates. There may be a sharp decline in milk production.  
The parotid lymph nodes, which drain the ear to which the infected tick has attached, are enlarged. After a few 
days the animal becomes depressed and lethargic. The temperature continues to rise, often to 41 or 42 °C. 
Anorexia may develop but is not inevitable. Lachrymation commonly occurs together with oedema of the 
eyelids, and may be accompanied by photophobia. The animal is often constipated. There is a generalized 
enlargement of the superficial lymph nodes; the prescapular and precrural nodes become very prominent [6].  
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The disease usually progresses over a period of about 15 days, but may terminate after five days or be 
prolonged to 25 days. Pregnant cows may abort. [6][9].  
In the terminal stages of the disease dyspnoea develops, with an increased respiratory rate, a watery cough and 
the discharge of frothy fluid from the nostrils. The discharge is copious both when the animal is recumbent and 
immediately before death. Sternal and submandibular oedema may be present. The enlarged superficial lymph 
nodes begin to regress, the rectal temperature falls to subnormal levels, and the animal becomes recumbent 
and dies in a coma.  
A small number of animals, usually about 5 per cent, may recover, but convalescence is prolonged and the 
animals may remain emaciated and unproductive for monthsThe disease may assume a less severe form in 
animals with partial immunity or inherent resistance, but pyrexia and enlargement of superficial lymph nodes 
remain constant features. Mild disease has also been reported occasionally following infection of fully 
susceptible animals with strains of T. parva of reduced virulence.  
In the Asiatic buffalo the disease resembles that in the ox, but in the African buffalo infection is invariably 
subclinical or mild.  
 
Immunity to T. parva  
The immune response to theileriae parasites is complicated. Cell-mediated immunity is thought to be the most 
important protective response in T. parva and T. annulata. In T. parva, the principal protective responses are 
mediated through the bovine major histocompatibility complex (MHC) class I-restricted cytotoxic T lymphocytes 
[12][22]  
Infection with the parasite results in an acute lymphoproliferative disorder with high mortality, but animals 
which survive infection are solidly immune to homologous challenge. Such immunity can be reproduced by 
infecting cattle with the parasite and treating them with tetracyclines or theilericidal drug: this characteristic is 
the basis of the infection and treatment immunisation method used for ECF.  
These have provided evidence that immunity to the parasite can operate at two levels: blocking of the infection 
by antibody specific for sporozoite surface antigen and killing of parasitized leucocytes by cytotoxic T cells.  
  
Humoral immunity 
• Animals in endemic areas respond to T. parva infection by mounting humoral responses that decline 
over months in the absence of challenge. The serum from immune cattle contains antibodies against all 
stages of the T. parva parasite [12].   
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• The most relevant antibody responses are those directed against sporozoite surface antigens [14]. 
Antibodies against sporozoites appear to recognise a wide range of T. parva isolates and are correlated 
with some protection [1].  
• In vitro studies have showed that a highly conserved 67-KDa protein (p67) and to a lesser extent the 
polymorphic immunodominant molecule (PIM) were the major neutralising antigens [16]. Immunisation 
of cattle with Escherichia-coli derived recombinant p67 gave approximately 70% protection of cattle 
against severe disease after laboratory challenge [14]. However, only a small proportion of immunised 
cattle were able to show complete neutralization of infection while the rest showed schizont parasitosis 
of varying severity.  
Cell-mediated immunity 
• There is strong evidence that the long lasting protective immune mechanisms in T. parva are 
cellmediated and targeted against the schizont-infected lymphocytes [12]. Animals subjected to a single 
immunisation by infection and treatment produce little or no sporozoite- neutralizing antibodies [14].   
• The principal effectors of the protective cellular immunity are CTLs directed against the schizontinfected 
lymphocyts [12][13].  
• The immune cells responsible for protection through lysis of infected cells belong to CD8+ T-cell 
subpopulation and are MHC class-I (MHC-I) restricted and parasite specific. The strain specificity of CTL 
response induced is consistent with the existence of immunological heterogeneity in populations of T. 
parva [13], which is maintained through sexual recombination in the vector [1]. 
• Other cellular mechanisms may also contribute to protection of immune cattle against challenge. 
Baldwin et al. [13] isolated parasite-specific CD4+ T cell clone with cytotoxic activity but their role in the 
immune response had not been determined.  
There seem to be evidence of resistance in some breed, such as the Ankole. This was demonstrated in a study 
published in 1991, where following challenges of Ankole cattle from Rwanda and cross-bred animals, it was 
concluded that the partial Theileria tolerance of the Ankole is, to a great extent, genetic. The basis of this partial 
tolerance seems to be their ability to limit the explosive multiplication of macroschizonts during the acute phase 
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The diagnosis of classical ECF is based on the characteristic clinical signs and lesions, and may be confirmed by 
demonstration of schizonts and, in the later stages of the disease, piroplasms.  
  
Clinical Diagnosis  
East Coast fever should be suspected in tick–infested animals with a fever and enlarged lymph nodes. Terminal 
pulmonary edema and a high mortality rate in introduced breeds are also suggestive. Indigenous animals with 
tropical theileriosis may be in poor condition, with wasting and signs of anemia.  
Pathology and post-mortem diagnosis  
In the dead animal, smears prepared from the cut surface of the spleen and any enlarged lymph nodes should 
be examined. Smears must be of good quality and should be stained with Giemsa or any other Romanowsky 
stain. The presence of large hyperplastic lymphoblasts should be an incentive to continue the search for 
schizonts if they are scanty [9].  
The most prominent feature seen in a carcass, is often the severe accumulation of fluid in the lungs, frequently 
also accompanied by large amounts of froth in the trachea and bronchi.   
Laboratory diagnosis  
In live animals, theileriosis can be diagnosed by finding schizonts in Giemsa-stained thin smears from peripheral 
blood or fine-needle aspirates of superficial lymph nodes, or lymph node biopsies. The piroplasmic stage follows 
the schizont stage and, it is usually less pathogenic and is thus often found in recovering or less acute cases [24].  
Microscopic examination and PCR constitute tests aimed at the identification of the agent.  o Serology is used in 
cross-sectional surveys or longitudinal studies to detect the presence of T. parva infection and to determine the 
prevalence, incidence and seasonality of infection and disease. Circulating antibodies were first demonstrated in 
recovered animals by the complement fixation test and since then various techniques, for detection of the 
immune response, have been developed using schizonts or piroplasms as antigen. Serological tests used are 
either the ELISA or the IFAT Table 2 below summarizes the different tests and circumstances of their use [24]. 
Important to note that the ELISA is currently used as an indication of immune response post vaccination both in 
the field and vaccine QC despite the fact that it is not ideal.  
Microscopy  
Multinucleate intralymphocytic and extracellular schizonts can be found in Giemsa-stained biopsy smears of 
lymph nodes, and are a characteristic diagnostic feature of acute infections with T. parva. Both intracellular and 
free-lying schizonts may be detected, the latter having been released from parasitised cells during preparation 
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of the smears. It is important to note that schizonts, which are the pathogenic stage of T. parva, and piroplasms 
of different theilerias are very difficult to discriminate in Giemsa-stained smears.  
Piroplasms of most species of Theileria may persist for months or years in recovered animals, and may be 
detected intermittently in subsequent examinations. However, negative results of microscopic examination of 
blood films do not exclude latent infection. Relapse parasitaemia can be induced with some Theileria species by 
splenectomy. Piroplasms are also seen in prepared smears at post-mortem, but the parasites appear shrunken 
and their cytoplasm is barely visible.  
 




























 Agent identifictaion [3] 
Microscopy 
examination 
- +++ - +++ - - 
PCR + ++ ++ +++ + - 
 Detection of Immune response [4] 
IFAT + +++ ++ - +++ - 
ELISA + + - - + - 
 
Key: +++ = recommended method; ++ = suitable method; + = may be used in some situations, but cost, reliability, or 
other factors severely limits its application; – = not appropriate for this purpose. Although not all of the tests listed as 
category +++ or ++ have undergone formal validation, their routine nature and the fact that they have been used widely 
without dubious results, makes them acceptable. PCR = polymerase chain reaction; IFAT = indirect fluorescent antibody 
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Molecular diagnostics  
The need for an improved method of detection of T. parva carrier animals has led to the development of a 
number of PCR techniques using T. parva-specific primers based on single copy genes (pl04 and PIM antigen 
genes) or a repetitive gene sequence (TpR).  
The tests developed to date include: o Conventional PCR followed by agarose gel electrophoretic analysis [10] o 
Nested-PCR,   
PCR followed by dot blotting, capillary blotting or slot-blotting and hybridisation using radioisotope labelled 
probes [10]  
Detection by molecular methods allow for direct confirmation of the presence of parasite genomic material, 
with the inference that live parasites are present in the animal at the moment of sampling. Developments from 
conventional to nested to real-time PCR has allowed improvement in sensitivity, quantification and speed of 
detection, while methods such as reverse line blot, bead arrays, pan-FRET assays and highresolution melt 
analysis hold the promise of detection of multiple species or genotypes at the same time [10].   
Real-time melting profile based assays also hold the advantage that variation in probe regions may be detected 
by differences in melting profiles that may be related to genotypic or species differences.  
Whereas many of these assays require specialized equipment, LAMP assays hold the advantage of functioning at 
isothermal conditions, with possible application under field conditions.  
 
Indirect Fluorescent Antibody Test  
The IFA test is robust, easy to perform and provides adequate sensitivity and specificity for use in the field for 
detection of prior infection with T. parva and T. annulata infections under experimental situations and in a 
defined epidemiological environment where only one theilerial species is present. [21].  
The IFAT remains the gold standard assay recommended by the OIE for international trade. o The IFAT can use 
either schizont or piroplasm antigen, but that using schizont antigen is the most widely used serological test for 
both species. It has been used extensively in ECF endemic areas, both to improve understanding of the 
epidemiology of theileriosis and to assess seroconversion in immunisation trials (Minjauw et al.; 2003).  The 
schizont IFAT for T. parva cross-reacts with T. annulata and T. taurotragi, but not with T. mutans. [24]. ELISA  
The IFAT utilises whole-body antigen, but the realisation that a select number of antigens are responsible for the 
dominant immune response against most Theileria parasites has stimulated interest in ELISA.  
Tests used are indirect ELISAs based on parasite-specific PIM antigen, found on the surface of sporozoites and 
schizonts. These ELISAs provide higher (over 95%) sensitivity than the IFA tests [24][10].  
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The ELISA detects antibody of IgG1 isotype and antibody levels remain positive after a single infection with T. 
parva for longer than with the IFAT.  
  
Differential Diagnosis  
In endemic areas ECF must be differentiated from other febrile conditions which usually terminate fatally after a 
course of one to two weeks and which feature progressive emaciation, respiratory distress, diarrhoea, corneal 
opacity and lymphoid hyperplasia [9].    
 Bovine virus diarrhoea/mucosal disease and bovine malignant catarrhal fever may all be distinguished by the 
presence of ulcerating or necrotizing inflammatory reactions in buccal and nasal mucosae, and conjunctivitis.  
CBPP: difference based on characteristic coughing and evidence of pain on respiration.  
Acute trypanosomosis does not exhibit diarrhoea or severe respiratory distress.  
Babesiosis and anaplasmosis: anaemia and icterus are the major presenting signs.  
     
East Coast Fever | Monograph 13 














In the 11 countries where ECF is endemic, outbreaks and fatalities due to the disease occur yearly, and are not 
always reported or recorded.  Below are data from official reporting at the OIE and the AU-IBAR, as well as 
prevalence data from publications.  
Prevalence is usually low (63%) in the endemic instability state (Deem et al 1993; Medley et al., 1993 and Perry 
and Young, 1995). Endemic stability is likely to exist where the prevalence of serum antibodies to infection is 
equal or greater than 70% (Lynen et al., 1999). Animals in endemic areas respond to Theileria parva infection by 
mounting humoral responses that decline over months in the absence of challenge.  
 
Incidence data by country 
Table 3: Number of Theileriosis outbreaks reported to the OIE between 2005-2015 (Numbers given only for 
the target countries). Source: OIE.   
http://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/statusdetail  
 
Country  2005  2006  2007  2008  2009  2010  2011  2012  2013  2014  2015  
    East Africa       
Ethiopia  0  0  0  0  0  0  0  0  0  0  -  
Kenya  +  >28  39  +  >10  10  +  >5  4  27  21  
Rwanda  -  +  +  +  +  +  +  +  +  -  -  
Tanzania  +  93  437  110  70  80  54  29  31  50  >19  
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Uganda  +  2  +  +  +  +  +  +  +  +  -  
    Southern Africa       
Malawi  >5  +  >3  -  >1  2  0  0  0  -  -  
Mozambique 5  +  16  >4  +?  0  0  0  -  -  -  
Zambia -  63  65  143  206  180  +  82  151  275  -  
 
-    No information,      +   Present but quantitative data not known,   ?  Disease suspected 
 
AU-IBAR:  The number of outbreaks reported to AU-IBAR is included in the Pan African Animal Resources Year 
Book. (http://www.au-ibar.org/pan-african-animal-resources-yearbook?showall=&limitstart=) and can be 
seen for the countries of interest in Table 4 below.    
 
Table 4: Number of Theileriosis outbreaks reported to the AU-IBAR from 2005 to 2015 (numbers given only 
for the target countries). Source: AU-IBAR Year Books. 
 
Country  2005*  2006*  2007  2008  2009  2010  2011  2012  2013  2014  2015  
    East Africa        
Ethiopia  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  




1356  791  260  34    
Rwanda                        









28  28  44    
Uganda      4  10  12  45  45    11  6    
Southern Africa       
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Country  2005*  2006*  2007  2008  2009  2010  2011  2012  2013  2014  2015  
Madagascar                        
Malawi          1      37        
Mozambique      2  17  4  10  10    8  6    
South Africa**      4  10  2      11    11    
Zambia      65  2  2585 
cases  
9  9  43  141  121    
 
*AU-IBAR didn’t start yet producing data for ECF  




No data or not recent prevalence data was found for Ethiopia, Malawi and Mozambique.  
Kenya  
Year  Area  Species of animal  No. of samples 
tested  
% positive  Reference  
2014  Western Kenya  Indigenous cattle  453  12.9%  
(Reverse line blot 
hybridization)  
Njiri et al, 2015  
2014  Western Kenya  Indigenous cattle  548  77%  
(serology)  
Kiara et al, 2014  
2011  Ngong  and  
Machakos  
Cattle  Ngong: 154  
Marchakos: 38  
Ngong:  
33.8% Theileria spp 
Machakos:  
39.5% Theileria spp  
Adjou Moumouni  
et al, 2015  
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2003  Mbeere District  Cattle  440  from 
 80  
farms  
19.3%  Skilton et al, 2003  
  
  
Table: ECF prevalence, incidence and case-fatality rates from studies conducted in traditional crop-livestock and 
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The table below includes unpublished data from the CTTBD for T. parva (TP) and T. mutans (TM)   





AREA /SITE SAMPLED NO. OF  
SAMPLES 
Positive cases per 
parasite 
2011  TP TM 2013  TP TM 
Natural Resources College 23 0 1 Mpalo MBG [Ntchisi] 9 3 1 
Central African Cattle 39 1 5 Mwera Mkaka MBG 
[Ntchisi] 
21 11 7 
Katete Dairy Farm 65 0 4 Mchinji 28 2 2 
Likasi Livestock Centre 30 3 2 Chitedze Research 
Station 
17 2 2 
Mapanga Dairy Farm [Blantyre] 27 0 0 Natural Resources 
College 
33 2 3 
Mpemba [Blantyre] 28 0 0 Mzuzu ADD 17 0 0 
Shire Highlands RDP [Blantyre] 58 2 3 Blantyre 238 5 31 
Blantyre 61 0 5 Kalata Farm [Lilongwe] 6 0 4 
Rujeri [Mulanje] 6 0 0 Ntchewu 83 0 0 
Chimbiya [Dedza] 12 1 0 2014  TP TM 
Ntchewu 2 0 0 Katete Dairy Farm 82 7 18 
2012  TP TM Mpalo MBG [Ntchisi] 49 1 7 
Natural Resources College 20 0 3 Blantyre 145 0 20 
Katete Dairy Farm 40 0 0 Magomero MBG 
[Lilongwe] 
40 0 6 
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asi Livestock Centre 
10 2 0 Chitedze Research 
Station 
8 2 3 
Mapanga Dairy Farm [Blantyre] 26 0 1 Golden Peacock [Salima] 12 0 1 
Mikolongwe area - [Chiradzulu] 14 0 2 Dzalanyama Ranch 10 0 0 
Blantyre 35 1 2 Chitipi 22 4 0 
Mbulumbuzi - [Chiradzulu] 30 1 8 Mchinji 56 11 13 
Chileka and Lunzu [Blantyre] 37 0 1 Kasungu 4 0 0 
Chigumula and Soche  [Blantyre] 53 0 3 2015  TP TM 
Mpemba [Blantyre] 76 1 8 Dzalanyama Ranch 6 0 4 
State House [Lilongwe] 32 0 0 Katete Dairy Farm 27 3 4 
Bvumbwe 18 1 1 Bunda College [Lilongwe] 10 9 0 
2013  TP TM Magomero MBG 
[Lilongwe] 
24 7 13 
Katete Dairy Farm 96 12 24 Natural Resources 
College 
14 5 0 
Magomero MBG [Lilongwe] 65 8 4 Likasi Livestock Centre 7 6 0 
Namwiri MBG [Dowa] 17 0 4 Chilikhanda Farm 10 0 4 
  
Rwanda  
Year  Area  Species of animal  No. of samples 
tested  
% positive  Reference  
2007?  Throughout the 
country  
Cattle    83-85%*  Bazarusanga, 2008  
* This was calculated using a Bayesian model which integrates PCR and serological methods. However, 
agreement between the sensitivity of PCR and serological methods was only achieved in the agro-ecological 
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zone of the mountainous region in the northern highland at 1,900 m altitude above sea level, where the lowest 
tick challenge was found (< 20 ticks per animals).  
  
Tanzania  
Year  Area  Species of animal  No. of samples 
tested  
% positive  Reference  
2013  Kilosa  district 
(Morogoro)  





Year  Area  Species 
animal  
of  No. of samples 
tested  
% positive  Reference  
2015  Whole country  Cattle   564  Disease predominates in 
Southwestern and 
Northeastern Uganda  




(Central and  
Western region)  









 925  30%  
For more details, see  
Table and Figure below  
Kabi et al, 2014  
2011  Tororo District  Cattle   2,658  Individual: 5.3 Herd: 0 - 
21  
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Figure 5: The spatial distribution of non-clinical T. parvo infection among indigenous cattle populations in 
Uganda: January 2011-April 2012.  Source: Kabi et al, 2014.  
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Year  Area  Species  of  
animal  
No. of samples 
tested  
% positive  Reference  
2008  Kanyelele, Kalembe  
(Isoka district – 
Northern province)  
and  Saukani  
(Petauke district)  
Indigenous and 
mixed breeds of  
cattle  
142  
Kanyelele: 62  
Kalembe: 34  
Saukani: 46  
54.9%  
Isoka: 44.8  
Petauke: 76.1  
(PCR)  
Muleya et al, 2012  
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Economic and Social Impacts at Global 







ECF has a devastating impact on pastoralists and smallholder farmers.  The economic impact of the disease 
includes cattle morbidity and mortality, and production losses in all production systems, as well as the costs of 
the measures taken to control ticks and the disease.   
 
The costs of acaricide applications, which is the primary means of tick control, is estimated to range between 
USD 6 -36 per adult animal in Kenya, Tanzania and Uganda. The disease further prevents the introduction of the 
ECF susceptible but more productive exotic breeds of cattle, hampering development in the livestock sector 
(Demessie and Derso, 2015).  The financial losses incurred, directly and indirectly by ECF are extremely high.   
Figures widely used in expressing the impact of ECF is that in the 11 affected countries, 28 million cattle are at 
risk, with the disease killing annually over one million cattle resulting in annual losses exceeding widely $300 
million [5][14]. According to the BMGF, the overall annual economic losses due to ECF are estimated to be USD 
382.64 million, with losses to small holder farmers estimated to be representing USD 286.98 million.  
 
In their study of the economic impact of Tick borne diseases on the livelihood of poor livestock keepers, 
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Figure 7: Annual costs per head of theileriosis compared to adult female value 
 
In Tanzania, ECF accounts for more than 70% of all cattle death annually [8], resulting in total costs assessed to be 
more than USD247 million annually (Table 5).  
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Table 5: Combined estimated annual direct costs associated with tick-borne diseases in Tanzania (million 
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The main methods in the control of ECF include tick control, host immunization and chemotherapy and 
integrated control that combines any of the methods. The most practical and widely used method for the 
control of theileriosis is the chemical control of ticks with acaricides. However, tick control practices are not 
always fully effective for a number of reasons, including development of acaricide resistance, the high cost of 
acaricides, poor management of tick control, and illegal cattle movement in many countries.  
• Chemotherapy is widely used in the treatment of clinical disease, sometimes to good effect, but they have 
not proved to be completely reliable therapeutic agents.   
• The only immunisation method that has been possible to use to date is the infection and treatment Method 
(ITM) described later in Section 6.  
• Other methods that have been tried in specific cases include Isolation of susceptible cattle maintained in a 
closed herd on properly fenced pastures; and Destocking infected pastures, by keeping them free of cattle for 
15 to 18 months, leading to a disappearance of the infection (these methods are impractical in endemic 
areas).   
 
Vector control 
In endemic areas, the tick burden can be decreased with acaricides and other methods of tick control such as 
rotational grazing.  
Tick control methods include direct application of acaricides to cattle through dipping, spray races, hand spray, 
pour-ons, and hand dressing.  
Although acaricides constitute the most widely used method for the effective control of ticks in most part of 
affected regions, the use has not been always efficient and is more and more resulting on increasing cases of tick 
resistance (ref.). In addition, acaricides are expensive and can be detrimental to the environment: their use 
should be minimised and integrated with alternative approaches.   
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In order to optimise the use of acaricides, farmers need to understand the biology and ecology of the tick 
species on their land, since an effective control strategy should use the available compounds at the most 
appropriate application frequency [14].  
Depending on the abundance and importance of the various tick species, strategies such as seasonal treatments 
at the peak of tick activity, or intensive dipping at the beginning of the tick season, may be sufficient to avoid 
economic losses due to ticks and TBDs.  
The use of immunisation and of tick-resistant breeds of cattle can also considerably reduce dependence on 
acaricides. For example, it is widely recognised that, compared to breeds of Bos taurus, Bos indicus has a much 
greater natural ability to acquire protective immunity against ticks [14].  
A brief description of the main methods of applying acaricides to cattle and of the types of acaricides available is 
given below (adapted from FAO, 1984 ftp://ftp.fao.org/docrep/fao/010/ag014e/ag014e05.pdf )  
 
Dipping tanks  
The dip tank is an efficient, practical and convenient means of applying acaricide to a herd of livestock. The 
characteristics of each dip tank will depend on the type of animals to be treated, but several important features 
should be included  
The advantages of a dipping tank are [2] :   
• The wetting of the animals is good.   
• The stripping rate is lower than in the spray race: the dip concentration is more stable during dipping. 
The disadvantages are:   
• An adequate source of clean water must be readily available to fill the dip initially and to ensure that 
top-ups can be made when required. This is often not possible in arid and semi-arid regions.   
• It requires a large initial capital outlay to fill the tank with acaricide.   
• Acaricides cannot be changed regularly.   
• The dipping fluid is often dirty and old and the strength is not known.   
• The concentration in the dip tank may change as a result of flooding or evaporation.   
• The suspension settles in the interval between dippings. Therefore 20 animals must be sent through to 
mix the fluid and these animals must be re-dipped. Alternatively, relatively large holes can be drilled in a 
circular plowshare, the centre of which is then welded to a metal pipe. The plowshare is then dunked to 
the bottom of the dip and pulled up again and the procedure repeated until the dip is well mixed.   
• The animals may be injured.  
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Spray race  
A spray race is a corridor or series of crushes permanently fixed in an infrastructure similar to a dip tank, in 
which animals passing through are sprayed with acaricides pumped at low pressure (but high volume) through 
nozzles placed along the race. Drained acaricide solution is filtered before being returned to a reservoir for re-
use. Spray races are very economical in their use of acaricide (2–3 l per adult bovine) and are also quick to 
operate (600 head per hr). However, because they incorporate various mechanical parts (engine, pumps, 
nozzles, etc.), they are more expensive and more difficult to maintain than dip tanks, a fact that has prevented 
them from being adopted by small-scale farmers in most developing countries The advantages of a spray race 
are:  
• The dip wash is always at the correct strength and fresh and evenly suspended in the fluid because it is 
made up at each dipping.  
• The cost of the acaricide is spread evenly throughout the year or season.  
• Acaricides may readily be alternated.  
• Injuries to the animals are unlikely to occur. The disadvantages of a spray race are:  
• Mechanical failure of the pump.  
• Wetting is not always complete, particularly of the ears and under the tail.  
• The stripping rate is high, resulting in a lower concentration of acaricide by the time the last animals are 
treated. Stripping implies that a higher concentration of acaricide clings to the animals and that the 
concentration of acaricide in the fluid that drips off the animals after they have been sprayed and that 
flows back into the sump is lower than that in the original spraying suspension.  
  
Hand spray  
Most small-scale farmers who own only a small number of animals cannot afford a dip tank or spray race, and 
many communal dips have fallen into disrepair as operational funding for veterinary services has declined. 
Handspraying is therefore often the method of choice.   
However, although this is the simplest method of treating livestock with acaricides, it is also potentially the least 
effective. The animals have to be tethered to posts or held in a crush so that the spray nozzle can be held 
sufficiently close to allow all parts of the body to be treated. Each animal should be sprayed with 10 litres of 
solution to ensure full and effective coverage. The procedure is time-consuming and its efficacy is highly 
dependent on the degree of care taken to ensure that all parts of the animal are treated. It is therefore only 
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Pour-on   
The acaricide, in a formulation containing effective spreaders, is administered along the top-line from the poll to 
the tail base. Pour-ons can be used when there are few or many cattle to be treated and require only a crush 
pen for handling the animals. Some of the endectocides administered as pourons are absorbed through the skin 
and reach their targets in this way.  
Pour-on formulations are expensive, but have the advantage of not requiring water or costly equipment for their  
application. They also have a persistent effect and protect animals against both ticks and biting flies Available 
and recommended acaricides include:  
• Organophosphates and carbamates: the most common being chlorphenvinphos, coumaphos, diazinon, 
dioxathion and carbaryl (carbamate). Important to note that several ticks, and particularly B. microplus, have 
developed resistance to organophosphates in many parts of the world   
• Pyrethroids : The synthetic pyrethroids are a highly effective group of acaricides that includes such 
compounds as permethrin, decamethrin, deltamethrin, cyhalothrin, cyfluthrin and flumethrin. Resistance to 
pyrethroids is widespread in 1-host ticks such as B. microplus and B. decoloratus [14]  
• Amidines: These compounds also show prolonged residual activity (7–10 days) and no residues are found in 
meat or milk. The only amidine compound commercialised for tick control is Amitraz   
• Macrocyclic lactones: Macrocyclic lactones (which include ivermectin, moxidectin, and doramectin) are not 
acaricides as such but are active against a variety of endo- and ectoparasites. A single treatment with one of 
the macrocyclic lactones will protect against ticks for up to 7–10 days. However, since ticks are only affected 
when they suck the blood of a treated animal, these compounds do not prevent tick damage or rapid 
inoculation with tick-borne pathogens. In addition, residues of these products can occur in the milk and meat 
of treated animals for several weeks after application.  
• Benzoylphenylureas: Benzoylphenylureas are growth regulators: they do not kill the ticks but disrupt their 
development and stop the moulting process. The best-known product, Fluazuron®  
(difluorobenzoyl urea) acts systematically and is applied to cattle as a pour-on, but has a long residual life in 
tissue and milk. These products are very effective against B. microplus and may be a solution where resistance to 
other acaricides is high (Ref).   
 
Treatment  
ECF proved refractory to treatment for many years until Neitz, in 1953, found that certain tetracyclines had a 
marked suppressive effect on the schizonts if administered during the incubation period. Tetracyclines have 
been widely used in the treatment of clinical disease, sometimes to good effect, but they have not proved to be 
completely reliable therapeutic agents. They have been used successfully, however, in immunization against 
East Coast fever by an infection-treatment technique [9]  
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An important breakthrough in the control of East Coast fever was achieved in the late 1970s by the development 
of two highly effective therapeutic agents. Parvaquone, a napthoquinone, known during its development trials 
as 993C, proved to be a valuable therapeutic agent when administered by intramuscular injection at a rate of 10 
mg/kg, repeated after 48 hours. Recovery rates of 90 per cent or better were recorded in field trials. The drug is 
effective against both schizonts and piroplasms, but treatment does not achieve a parasitological cure, and 
recovered animals may remain intermittent carriers and some may take several months to return to normal 
productivity. An analogue of parvaquone (Clexon®), named buparvaquone, has been developed91 and has 
replaced parvaquone on the commercial market [9]  
The most largely commercially available drug in use against Theileria today are therefore halofuginone lactate 
(Terit®), Parvaquone (Clexon®), and subsequent more active analogue of Parvaquone, Buparvaquone (Butalex®). 
All three drugs are currently available but are extremely expensive, so that the cost of treating small indigenous 
cattle of low productivity may be equal to the value of the animals. Treatment in any case is only likely to be 
successful if carried out early enough to limit the development of the schizont stage of the parasite and 
subsequent damage to the immune system. Furthermore, none of these compounds will eliminate carrier 





The only commercially available vaccine against T. parva is an infection-and-treatment method (ITM) which 
consists of a live sporozoite challenge together with simultaneous treatment of the resultant infection with 
oxytetracycline. This procedure induces a controlled disease reaction which results in a mild infection and a solid 
protective immunity to homologous parasite challenge. In the absence of further challenge, this immunity lasts 
for over 36 months, but with regular natural exposure to the parasite, it should persist for the entire life of the 
animal. The ITM is further discussed in section 6 below.    
Disease situation and government policies by country 
Tables 6 and 7 below have been completed with the information received so far from the questionnaires sent to 
the DG and DVS.  This information will be updated and completed once the results from the different countries 
are received.   
Table 6 covers the disease situation (if it is notifiable or not), the presence of official surveillance and/or control 
programs, and the treatment situation.  Table 7 refers to vaccination.  
The definitions that were given to the respondents are:  
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1Surveillance: is the systematic ongoing collection, collation and analysis of data and the timely dissemination of 
information to those who need to know so that action can be taken.   
2Control: a program which is approved, and managed or supervised by the Veterinary Authority of a country for 
the purpose of controlling a vector, pathogen or disease by specific measures applied throughout that country, 
or within a zone or compartment of that country.  
 Table 6: Official status, official programs for ECF in the countries of interest  
 






If yes, active 













Kenya  Yes  Yes, passive  No  Yes  Yes  
Madagascar            
Malawi            
Mali  Yes  Yes, passive  Yes  Yes  Yes  
Mozambique            
Rwanda  -  -  -  -  -  
South Africa            
Tanzania   No  Yes, passive  Yes  Yes  Yes  
Uganda  No  No  No  Yes  Yes  
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Table 7: Vaccination for ECF in the countries of interest   
 















Species vaccinated  
(cattle, sheep, goats, 
pigs, poultry)  
Kenya  No  Farmers  Both  Cattle  
Madagascar          
Malawi  No  Combination  Both  Cattle  
Mozambique          
Rwanda  -  -  -  -  
South Africa          
Tanzania   No  Farmers  Private  Cattle  
Uganda  No  Farmers  Private  Cattle  
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The only commercially available vaccine against T. parva is an infection-and-treatment method (ITM) which 
involves the inoculation of potentially lethal dose of sporozoites and treatment with long acting oxytetractine 
(OTC). This procedure induces a controlled disease reaction which results in a mild infection and a solid 
protective immunity to homologous parasite challenge. In the absence of further challenge, this immunity lasts 
for over 36 months, but with regular natural exposure to the parasite, it should persist for the entire life of the 
animal.  
The method was developed by a team of scientists working in Kenya on an FAO project, inspired by the 
observation made by Neitz in 1953 that chlortetracycline (Aureomycin) during the ECF incubation period had a 
marked suppressive effect on the development of infection and permitted the establishment of a solid immunity 
[9].   
As illustrated in Figure 8 below, a crude suspension of sporozoites is prepared from adult ticks which have fed as 
nymphs on infected cattle, have moulted, and have been pre-fed on rabbits for three to four days to allow the 
sporozoites to mature. The suspension is mixed with glycerol as a cryoprotectant and stored, deep-frozen at 
−70°C or in liquid nitrogen. Aliquots are titrated in susceptible cattle to determine an optimum dose for 
immunization.  
While ITM provide good immunity against homologous immunizing strains, it is not consistently successful 
against unrelated strains. This situation led to efforts directed towards finding a broad spectrum stick or 
combination of stocks that could provide protection against a wide range of antigenically distinct T. parva 
parasites. On the basis of extensive cross-immunity trials, three isolates, identified as cattle-derived  
T. parva Muguga and T. parva Kiambu 5 and buffalo-derived T. parva Serengeti transformed, have been 
combined in the so-called Muguga cocktail [9].  
The Muguga cocktail provides protection against most isolates from outbreaks of East Coast fever in eastern 
Africa and is used in Tanzania, Kenya, Uganda and Malawi. It has also been found to be suitable and used for use 
in South Sudan, Eastern DR Congo and Rwanda.  
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Figure 8: Flow diagram illustrating the steps in production of individual stabilates of the Muguga cocktail 
ECF ITM (source Di Giulio et al. 2009)   
 
Given the fact that the ITM leads to a persistent infection with specific strains included in the vaccine, which 
may not be present in all areas, there is always a risk of introducing parasites of an antigenic type against which 
local cattle may have no immunity, and also complicating the situation of these areas. This situation had brought 
certain countries to use local stocks for immunization within affected regions:   
• In Eastern Zambia a local isolate known as T. parva Katete is used; and the Chitongo strain is used in Southern 
Zambia  
• In Kenya, an isolate from the Coastal region called Marikebuni has been used countrywide   
• In Zimbabwe a cattle-derived T. parva called Boleni has been used. It is a mild strain that has decreased in 
virulence through passage. As a result it was used in immunization without treatment [14]. According to 
Lawrence et al., Theileria parva Boleni has also been shown to protect cattle against several cattlederived T. 
parva stocks from Kenya and two buffalo-derived strains. This raises, according to the authors, the possibility 
of using T. parva Boleni more widely as a vaccine against ECF, although the fact that it induces the carrier 
state in immunized animals may make some reluctant to use it.  
  
Due to the very complex, time consuming, unpredictable and expensive production process, the ITM has not 
been available to cover most of the needs. As an illustration, production and laboratory testing of a batch of the 
trivalent Muguga Cocktail (MC) stabilate for immunization of a million cattle requires approximately 130 cattle 
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and 500 rabbits. In addition, application of at least 600,000 nymphal ticks to infected cattle is required to 
provide sufficient infected ticks for monitoring of infection levels and stabilate production [3]. The production of 
a batch takes around 18 months.  
On the efficacy side, recent work by Sitt et al. has added to the widely observed fact that the Muguga cocktail 
doesn’t protect against buffalo derived T. parva [22]  
It is also important to note the genetic similarity found by Norling et al. between the Serengeti-transform and 
Muguga stocks of the Muguga cocktail 51[18]  
  
On the vaccination side, the ECF ITM has a number of challenges that has made its use quite complex  
• Firstly the requirement for transport in liquid nitrogen has always created serious logistical challenge for its 
wider distribution,   
• The complexity of the infection and treatment process creates a requirement for skilled veterinarians for 
effective delivery.   
• The price of the immunization and treatment operation is generally quite high, generally between USD 10 
and 20 per animal (Uganda dissertation). Experience in affected countries however has shown that price is 
not generally an issue for livestock owners   
 
Commercial vaccines manufactured in Africa and Asia  
 
Table 8: Vaccination for ECF in the countries of interest   
 




Centre for Ticks and Tick borne 
diseases  
Malawi  Muguga cocktail   ITM  Malawi, Tanzania, 
Uganda, Kenya?  
Chitongo  ITM  Zambia  
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Although KARI has been involved in the development and production of the Marikebuni stock of ECF, there is no 
evidence that production is still ongoing.  
There is almost no information whether Zimbabwe still produces the Boleni vaccine.   
 
Commercial vaccines imported into Africa and Asia 
 
The information summarised in Table 9, is based on a questionnaire send to the Director of Veterinary Services 
office and regulators of the countries of interest.  Note that some vaccines might have been imported under DVS 
dispensation, and they are not necessary licensed in the country.   

























Kenya  -  -  -  -  -  -  -  
Madagascar                
Malawi  -  -  -  -  -  -  -  
Mozambique                
Rwanda  -  -  -  -  -  -  -  
South Africa                
Tanzania*†        250  215  500    
Uganda*  Muguga  
Cocktail  
  Kenya  0  45,000      
Zambia  -  -  -  N/A  N/A  N/A    
 
* Source: Local regulatory agencies  
† The figures provided by the regulatory authority seem underestimated   
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Table 10: Vaccine imported into the different countries.  
 
 
Attribute  Minimum (current available vaccine)  Ideal  
1  Antigen  
  
Immunogen with protective antigens 
of T. parva  
Immunogen capable of providing full 
protection in cattle against T. parva 
infection  
2  Indication for use  For active immunization of cattle   For active immunization of cattle   
3  Recommended species  
  
Cattle  All T. parva susceptible livestock   
4  Recommended dose  
  
1 ml  1 ml  




vaccine) or ready to use solution 
(inactivated vaccine)  
Ready to use solution/suspension  
6  Route of administration  
  
SC  SC, Intramuscular or pour on  
7  Regimen - primary 
vaccination  
Single dose  Single lifetime dose  
8  Regimen - booster  Single annual booster  Lifelong immunity after primary 
vaccination  
East Coast Fever | Monograph 13 






9  Epidemiological relevance  Protection against all geographically 
distinct strains of T. parva   
Protection against T. parva and 
prevention of transmission  
10  Recommended age at first 
vaccination  
Animals over 3 months: one injection  
  
From 1-2 months of age   
11  Onset of immunity  
  
2-3 weeks following primary 
vaccination  
One week following primary 
vaccination  
12  Duration of immunity  
  
At least 1 year  
  
Lifelong immunity  
13  Expected efficacy  To prevent disease & prevent 
mortality.  
To prevent infection and transmission. 
No disease & no mortality in vaccinated 
animals after virulent challenge.  
14  Expected safety  In animals under 6 months of age, a 
transient pyrexia reaction can occur.  
A transient nodular reaction of 
varying importance, may appear at 
the injection site, it progressively 
disappears within 1 to 2 months.  
Only vaccinate pregnant animals on 
emergency.  
No post-vaccinal reactions at any age.  
Safe for pregnant animals.   
No carrier form in vaccinated animals  
15  Withdrawal period  
  
Nil  Nil  
16  Special requirements for 
animals  
Do not vaccinate un-healthy animals  DIVA  
17  Special requirements for 
persons  
 None  None  
18  Package size  
  
50 doses  Multiple pack size from 10 doses  
19  Price to end user  
  
Not more than $0.50/dose  $0.20/dose at end user   
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20  Storage condition and 
shelf-life as packaged for 
sale  
12 months at 4-8° C    
  
 24 months 4-8° C and/or 48 hours at  
30° C  
  
21  In-use stability  
  




Overall conclusion for improved ECF control through vaccination  
The activities included in the ECF Consortium project covers all possible areas that could lead to a better vaccine 
or immunisation approach. All groups with some expertise on ECF are involved in the consortium.  
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Annex 1: Additional data on disease presence and 
incidence 
 
Reports to OIE on Theileriosis:   
  
When different animal health statuses between domestic and wild animal population are provided, the box is 
split in two: the upper part for domestic animals, and the lower part for wild animals.    
Theileriosis in Eastern Africa:  Ethiopia, Kenya, Rwanda, Tanzania and Uganda  
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Theileriosis in Southern Africa: Malawi, Mozambique and Zambia  
 
 
 
 
 
